Martin Wiesenfeld
- Oncology top 5%
- Colorectal Cancer Treatments and Studies 9
- Cancer Treatment and Pharmacology 7
- Lung Cancer Research Studies 7
- Pancreatic and Hepatic Oncology Research 4
- Cancer Research top 10%
- Hepatology top 10%
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment 4
-
- Neuroendocrine Tumor Research Advances 6
-
- Cancer therapeutics and mechanisms 6
-
- Lung Cancer Treatments and Mutations 5
- Co-authors
- James E. KrookTom R. FitchRoscoe F. MortonJ A MailliardKendrith M. RowlandEdith A. PerezSteven R. AlbertsPatrick J. Flynn
- Cited by
- OncologyCancer ResearchHepatology
- Journals
- Journal of Clinical Oncology (9 papers)Cancer (2 papers)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United StatesCanadaBelgium
In The Last Decade
Martin Wiesenfeld
33 papers receiving 954 citations
Peers
Comparison fields: 5 of 89
- Oncology 626
- Cancer Research 177
- Hepatology 64
- Pathology and Forensic Medicine 137
- Genetics 76
Countries citing papers authored by Martin Wiesenfeld
This map shows the geographic impact of Martin Wiesenfeld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Wiesenfeld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Wiesenfeld more than expected).
Fields of papers citing papers by Martin Wiesenfeld
This network shows the impact of papers produced by Martin Wiesenfeld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Wiesenfeld. The network helps show where Martin Wiesenfeld may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Martin Wiesenfeld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 6 | |
| 2 | 2008 | 132 | |
| 3 | 2008 | 28 | |
| 4 | 2007 | 12 | |
| 5 | 2005 | 83 | |
| 6 | 2003 | 1 | |
| 7 | 2003 | 9 | |
| 8 | 2003 | 49 | |
| 9 | 2003 | 52 | |
| 10 | 2003 | 25 | |
| 11 | 2002 | 24 | |
| 12 | 1997 | 35 | |
| 13 | 1996 | 10 | |
| 14 | 1995 | 25 | |
| 15 | 1995 | 53 | |
| 16 | 1994 | 53 | |
| 17 | 1994 | 10 | |
| 18 | 1993 | 36 | |
| 19 | 1991 | 6 | |
| 20 | cis-dichlorodiammineplatinum(II) with and without ICRF-159 in non-Hodgkin's lymphoma. | 1980 | 4 |
About Martin Wiesenfeld
Martin Wiesenfeld is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine, having authored 33 papers that have together received 982 indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (7 papers), Lung Cancer Research Studies (7 papers), Neuroendocrine Tumor Research Advances (6 papers), Cancer therapeutics and mechanisms (6 papers), Lung Cancer Treatments and Mutations (5 papers), Pancreatic and Hepatic Oncology Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Oncology (626 citations), Cancer Research (177 citations) and Hepatology (64 citations). Martin Wiesenfeld has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include James E. Krook, Tom R. Fitch, Roscoe F. Morton, J A Mailliard, Kendrith M. Rowland, Edith A. Perez, Steven R. Alberts, Patrick J. Flynn, Daniel J. Sargent and Alvaro Moreno‐Aspitia. Their work appears in journals such as Journal of Clinical Oncology, Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.